135 related articles for article (PubMed ID: 37148430)
1. Development of a perfusion process for continuous lentivirus production using stable suspension producer cell lines.
Klimpel M; Terrao M; Ching N; Climenti V; Noll T; Pirzas V; Laux H
Biotechnol Bioeng; 2023 Sep; 120(9):2622-2638. PubMed ID: 37148430
[TBL] [Abstract][Full Text] [Related]
2. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
3. Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing.
Tran MY; Kamen AA
Front Bioeng Biotechnol; 2022; 10():887716. PubMed ID: 35774066
[TBL] [Abstract][Full Text] [Related]
4. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
5. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture.
Broussau S; Jabbour N; Lachapelle G; Durocher Y; Tom R; Transfiguracion J; Gilbert R; Massie B
Mol Ther; 2008 Mar; 16(3):500-7. PubMed ID: 18180776
[TBL] [Abstract][Full Text] [Related]
6. Characterization of lentiviral vector production using microwell suspension cultures of HEK293T-derived producer cells.
Guy HM; McCloskey L; Lye GJ; Mitrophanous KA; Mukhopadhyay TK
Hum Gene Ther Methods; 2013 Apr; 24(2):125-39. PubMed ID: 23461548
[TBL] [Abstract][Full Text] [Related]
7. Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.
Stewart HJ; Leroux-Carlucci MA; Sion CJ; Mitrophanous KA; Radcliffe PA
Gene Ther; 2009 Jun; 16(6):805-14. PubMed ID: 19262613
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral Vector Bioprocessing.
Perry C; Rayat ACME
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572347
[TBL] [Abstract][Full Text] [Related]
9. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture.
Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M
J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417
[TBL] [Abstract][Full Text] [Related]
10. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral Vector Production in Suspension Culture Using Serum-Free Medium for the Transduction of CAR-T Cells.
Do Minh A; Tran MY; Kamen AA
Methods Mol Biol; 2020; 2086():77-83. PubMed ID: 31707669
[TBL] [Abstract][Full Text] [Related]
12. Transition from serum-supplemented monolayer to serum-free suspension lentiviral vector production for generation of chimeric antigen receptor T cells.
Tirapelle MC; Oliveira Lomba AL; Silvestre RN; Mizukami A; Covas DT; Picanço-Castro V; Swiech K
Cytotherapy; 2022 Aug; 24(8):850-860. PubMed ID: 35643755
[TBL] [Abstract][Full Text] [Related]
13. Exploring nutrient supplementation and bioprocess optimization to improve the production of lentiviral vectors in serum-free medium suspension cultures.
Vaz TA; Rodrigues AF; Coroadinha AS
Biotechnol J; 2024 Jan; 19(1):e2300212. PubMed ID: 37903159
[TBL] [Abstract][Full Text] [Related]
14. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.
Humbert O; Gisch DW; Wohlfahrt ME; Adams AB; Greenberg PD; Schmitt TM; Trobridge GD; Kiem HP
Mol Ther; 2016 Aug; 24(7):1237-46. PubMed ID: 27058824
[TBL] [Abstract][Full Text] [Related]
15. Transient Lentiviral Vector Production Using a Packed-Bed Bioreactor System.
McCarron A; Donnelley M; McIntyre C; Parsons D
Hum Gene Ther Methods; 2019 Jun; 30(3):93-101. PubMed ID: 31084376
[TBL] [Abstract][Full Text] [Related]
16. Progress and Perspectives in the Development of Lentiviral Vector Producer Cells.
Ferreira MV; Cabral ET; Coroadinha AS
Biotechnol J; 2021 Jan; 16(1):e2000017. PubMed ID: 32686901
[TBL] [Abstract][Full Text] [Related]
17. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
18. Development of an all-in-one lentiviral vector system based on the original TetR for the easy generation of Tet-ON cell lines.
Benabdellah K; Cobo M; Muñoz P; Toscano MG; Martin F
PLoS One; 2011; 6(8):e23734. PubMed ID: 21876765
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors.
Farson D; Harding TC; Tao L; Liu J; Powell S; Vimal V; Yendluri S; Koprivnikar K; Ho K; Twitty C; Husak P; Lin A; Snyder RO; Donahue BA
J Gene Med; 2004 Dec; 6(12):1369-81. PubMed ID: 15538729
[TBL] [Abstract][Full Text] [Related]
20. Genome editing for scalable production of alloantigen-free lentiviral vectors for
Milani M; Annoni A; Bartolaccini S; Biffi M; Russo F; Di Tomaso T; Raimondi A; Lengler J; Holmes MC; Scheiflinger F; Lombardo A; Cantore A; Naldini L
EMBO Mol Med; 2017 Nov; 9(11):1558-1573. PubMed ID: 28835507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
